SuperBio Labs
  • Products ▾
    View all products → MetabolicWeight management · GLP-1 family RecoveryTissue repair and injury recovery LongevitySkin, collagen and anti-aging HormonalGrowth hormone · sleep · libido CognitiveFocus and mental clarity Skin / AestheticsSkin, collagen and aesthetics GutGut and digestive health LibidoDesire and sexual function Energy / MitoCellular energy and mitochondria
    Find your ideal kit →
  • Find your ideal kit
  • The Reference
  • Resources ▾
    Peptides 101 The Peptide Bible The Reference Dose calculator
  • Quality ▾
    See the ≥99% purity standard →
    How we select peptidesCurated by science, not by catalog. Quality standardsHPLC, LC-MS, endotoxins and 2-8°C cold chain. Verify COALook up your batch certificate of analysis.
  • About ▾
    Who we are Contact us For health professionals
ES EN
Cart 0
  • Shop
  • Products
  • Categories
  • Find your ideal kit
  • Resources
  • The Reference
  • Peptides 101
  • The Peptide Bible
  • Dose calculator
  • Quality
  • How we select
  • Quality standards
  • Verify COA
  • About
  • Who we are
  • Contact us
  • For health professionals
ES EN
Free advisory

"The sale is the first step. The post-sale service is what changes the game."

SuperBio Labs · Last updated: 2026-05-20 · v2.0

Disclaimer · Investigational products

Terms under which SuperBio Labs supplies peptides at various stages of the regulatory process.

SuperBio Labs is a brand operated by SGI LLC, a company incorporated in Wyoming, USA, with commercial operations based in Quito, Ecuador. This notice establishes the terms under which SuperBio Labs supplies its products. By purchasing any product from the catalog, the buyer acknowledges and accepts the terms described below.

1. Nature of products

SuperBio Labs offers peptides in active clinical investigation, manufactured with HPLC ≥99% purity and an independent Certificate of Analysis (COA) per batch. Each compound is at a specific stage of the international regulatory process:

ProductRegulatory status
5-Amino-1MQResearch stage · preclinical · no human trials
United States: in research
TesamorelinMolecule approved in United States and Canada · 2010
United States: approved · Canada: approved
TirzepatideMolecule approved in United States, European Union, United Kingdom and 5 more · 2022
United States: approved · European Union: approved · United Kingdom: approved · Japan: approved · China: approved · Canada: approved · Australia: approved · Brazil: approved
RetatrutidePhase 3 complete · BLA announced for 2027
United States: phase 3 complete
MOTS-cCompounding pharmacies in United States can now prepare it · Oct 2026
United States: compounding pharmacies may prepare it
GHK-CuResearch stage · cosmetic ingredient in United States and European Union
European Union: cosmetic ingredient · United States: cosmetic ingredient
TB-500Compounding pharmacies in United States can now prepare it · Oct 2026
United States: compounding pharmacies may prepare it
KPVCompounding pharmacies in United States can now prepare it · Oct 2026
United States: compounding pharmacies may prepare it
BPC-157Compounding pharmacies in United States can now prepare it · Oct 2026
United States: compounding pharmacies may prepare it
EpithalonCompounding pharmacies in United States can now prepare it · Oct 2026
United States: compounding pharmacies may prepare it
SemaxRegistered medicine in Russia · pharmacies in United States can now prepare it
Russia: registered medicine · United States: compounding pharmacies may prepare it
PT-141Molecule approved in United States · 2019
United States: approved
SS-31Molecule approved in United States · 2025 · orphan designation in European Union
United States: approved · European Union: orphan designation
NAD+Research stage · cellular metabolism
United States: in research
GlutathioneMolecule approved in Italy
Italy: approved · United States: in research
SelankRegistered medicine in Russia
Russia: registered medicine
AHK-CuResearch stage · cosmetic ingredient in United States and European Union
European Union: cosmetic ingredient · United States: cosmetic ingredient
AOD-9604Research stage · obesity trial unsuccessful
United States: in research
CagrilintidePhase 3 complete · under review in United States since Dec 2025
United States: under review
CJC-1295 + IpamorelinResearch stage · both in research
United States: in research
KisspeptinResearch stage · academic human trials
United States: in research
BlendsCombinations of the above compounds in informed-use proportions

Products are intended for research protocols, use under qualified medical supervision, and exploratory clinical applications. Clinical application is at the discretion and responsibility of the treating physician or investigator.

2. Buyer qualification

By placing an order, the buyer declares and warrants that:

  • They are 18 years of age or older according to the jurisdiction of their residence.
  • They acquire the products in the context of a legitimate activity: scientific research, development, qualified medical supervision, exploratory clinical application, or use under informed professional judgment.
  • They fully understand the investigational nature of the compounds and the specific regulatory status of each product.
  • They will comply with all laws, regulations, and applicable standards in their jurisdiction regarding handling, storage, and disposal.

3. Technical and scientific information

The information published at superbiolabs.com (including mechanism-of-action descriptions, suggested protocols, result timelines, reference doses, and combinations) is for informational and educational purposes only, based on published scientific literature and available clinical data.

This information is general and educational: medical advice, individual-use recommendations, prescriptions and therapeutic protocols come from a qualified medical professional familiar with the patient's specific context.

References to clinical trials (TRIUMPH, SURMOUNT, REDEFINE, STEP, SUSTAIN, among others) and published scientific literature are included for scientific context and evidence traceability.

4. Limitation of liability

SuperBio Labs guarantees the identity, HPLC ≥99% purity, and documented quality of each product delivered, verifiable through the corresponding batch COA. Beyond this product guarantee, SuperBio Labs assumes no responsibility for:

  • The end use that the buyer or third parties make of the products supplied.
  • Clinical applications, doses, frequencies, or combinations decided by the buyer or their treating physician.
  • Consequences arising from inadequate handling, storage, or disposal.
  • Adverse reactions, side effects, or individual clinical outcomes.
  • Interactions with other medications, supplements, or pre-existing conditions not disclosed to the medical professional.

5. Buyer compliance

It is the buyer's exclusive responsibility to verify and comply with applicable regulations in their jurisdiction regarding importation, possession, handling, and disposal of the products. SuperBio Labs is not responsible for customs holds, seizures, fines, or regulatory consequences arising from buyer non-compliance with local laws.

6. Modifications

SuperBio Labs reserves the right to update this disclaimer at any time. The current version is always the one published at superbiolabs.com/en/legal/disclaimer/.

By completing a purchase at superbiolabs.com, the buyer confirms having read, understood, and accepted this disclaimer in its entirety. Any inquiry may be directed to hello@superbiolabs.com.

SuperBio Labs

Products

  • Metabolic
  • Recovery
  • Longevity
  • Hormonal
  • Cognitive

Company

  • About us
  • Standards
  • Reconstitution calculator
  • The Reference
  • Verify COA
  • Contact
  • For health professionals
  • Distribute your brand

Legal

  • Disclaimer
  • Terms
  • Privacy
  • Shipping
© 2026 SGI LLC · Wyoming, USA superbiolabs.com · hello@superbiolabs.com